Rengifo E - Search Results

1

Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids.

Vázquez AM, Alfonso M, Lanne B, Karlsson KA, Carr A, Barroso O, Fernández LE, Rengifo E, Lanio ME, Alvarez C, et al. Vázquez AM, et al. Among authors: rengifo e. Hybridoma. 1995 Dec;14(6):551-6. doi: 10.1089/hyb.1995.14.551. Hybridoma. 1995. PMID: 8770642

2

A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors.

Carr A, Mullet A, Mazorra Z, Vázquez AM, Alfonso M, Mesa C, Rengifo E, Pérez R, Fernández LE. Carr A, et al. Among authors: rengifo e. Hybridoma. 2000 Jun;19(3):241-7. doi: 10.1089/02724570050109639. Hybridoma. 2000. PMID: 10952412

3

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System.

Blanco R, Rengifo E, Cedeño M, Rengifo CE, Alonso DF, Carr A. Blanco R, et al. Among authors: rengifo e, rengifo ce. ISRN Gastroenterol. 2011;2011:645641. doi: 10.5402/2011/645641. Epub 2010 Dec 2. ISRN Gastroenterol. 2011. PMID: 21991524 Free PMC article.

4

Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.

Blanco R, Rengifo E, Rengifo CE, Cedeño M, Frómeta M, Carr A. Blanco R, et al. Among authors: rengifo e, rengifo ce. ISRN Dermatol. 2011;2011:848909. doi: 10.5402/2011/848909. Epub 2011 Apr 10. ISRN Dermatol. 2011. PMID: 22363862 Free PMC article.

5

Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study.

Osorio M, Gracia E, Rodríguez E, Saurez G, Arango Mdel C, Noris E, Torriella A, Joan A, Gómez E, Anasagasti L, González JL, Melgares Mde L, Torres I, González J, Alonso D, Rengifo E, Carr A, Pérez R, Fernández LE. Osorio M, et al. Among authors: rengifo e. Cancer Biol Ther. 2008 Apr;7(4):488-95. doi: 10.4161/cbt.7.4.5476. Epub 2007 Jan 2. Cancer Biol Ther. 2008. PMID: 18285705 Free article. Clinical Trial.

6

Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin.

Blanco R, Quintana Y, Blanco D, Cedeño M, Rengifo CE, Frómeta M, Ríos M, Rengifo E, Carr A. Blanco R, et al. Among authors: rengifo e, rengifo ce. J Biomark. 2013;2013:602417. doi: 10.1155/2013/602417. Epub 2013 Jan 9. J Biomark. 2013. PMID: 26317019 Free PMC article.

7

Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences.

Blanco R, Domínguez E, Morales O, Blanco D, Martínez D, Rengifo CE, Viada C, Cedeño M, Rengifo E, Carr A. Blanco R, et al. Among authors: rengifo e, rengifo ce. Patholog Res Int. 2015;2015:132326. doi: 10.1155/2015/132326. Epub 2015 Nov 8. Patholog Res Int. 2015. PMID: 26634172 Free PMC article.

8

Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.

Blanco R, Rengifo CE, Cedeño M, Frómeta M, Rengifo E, Carr A. Blanco R, et al. Among authors: rengifo e, rengifo ce. Patholog Res Int. 2012;2012:235418. doi: 10.1155/2012/235418. Epub 2012 Feb 26. Patholog Res Int. 2012. PMID: 22482082 Free PMC article.

9

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.

Blanco R, Blanco D, Quintana Y, Escobar X, Rengifo CE, Osorio M, Gutiérrez Z, Lamadrid J, Cedeño M, Frómeta M, Carr A, Rengifo E. Blanco R, et al. Among authors: rengifo e, rengifo ce. Patholog Res Int. 2013;2013:920972. doi: 10.1155/2013/920972. Epub 2013 Nov 28. Patholog Res Int. 2013. PMID: 24381785 Free PMC article.

10

Immunohistochemical recognition of the epidermal growth factor receptor by the h-R3 antibody in the skin of experimental animals.

Maceira M, Rengifo E, Cedeño M, Merino N, Casacó Parada A. Maceira M, et al. Among authors: rengifo e. Appl Immunohistochem Mol Morphol. 2004 Dec;12(4):360-3. doi: 10.1097/00129039-200412000-00013. Appl Immunohistochem Mol Morphol. 2004. PMID: 15536338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters